Death during Intensive Glycemic Therapy of Diabetes: Mechanisms and Implications
- 1 November 2011
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 124 (11) , 993-996
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to ComorbiditiesThe American Journal of Medicine, 2011
- Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsBMJ, 2011
- Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD TrialDiabetes Care, 2010
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Long-Term Effect of Diabetes and Its Treatment on Cognitive FunctionNew England Journal of Medicine, 2007
- Hypoglycemia, functional brain failure, and brain deathJournal of Clinical Investigation, 2007